CoChat
Cited by 27

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Neurotoxic microglial activation via IFNγ-Induced Nrf2 reduction exacerbating alzheimer's disease

Kang, You Jung, Hyeon, Seung Jae, McQuade, Amanda, Lim, Jiwoon, Baek, Seung Hyun, Diep, Yen N., Do, Khanh V., Jeon, Yeji, Jo, Dong‐Gyu, Lee, C. Justin, Blurton‐Jones, Mathew, Ryu, Hoon, Cho, Hansang · 2024 · Advanced Science

Abstract

Microglial neuroinflammation appears to be neuroprotective in the early pathological stage, yet neurotoxic, which often precedes neurodegeneration in Alzheimer's disease (AD). However, it remains unclear how the microglial activities transit to the neurotoxic state during AD progression, due to complex neuron‐glia interactions. Here, the mechanism of detrimental microgliosis in AD by employing 3D human AD mini‐brains, brain tissues of AD patients, and 5XFAD mice is explored. In the human and animal AD models, amyloid‐beta (Aβ)‐overexpressing neurons and reactive astrocytes produce interferon‐gamma (IFNγ) and excessive oxidative stress. IFNγ results in the downregulation of mitogen‐activated protein kinase (MAPK) and the upregulation of Kelch‐like ECH‐associated Protein 1 (Keap1) in microglia, which inactivate nuclear factor erythroid‐2‐related factor 2 (Nrf2) and sensitize microglia to the oxidative stress and induces a proinflammatory microglia via nuclear factor kappa B (NFκB)‐axis. The proinflammatory microglia in turn produce neurotoxic nitric oxide and proinflammatory mediators exacerbating synaptic impairment, phosphorylated‐tau accumulation, and discernable neuronal loss. Interestingly, recovering Nrf2 in the microglia prevents the activation of proinflammatory microglia and significantly blocks the tauopathy in AD minibrains. Taken together, it is envisioned that IFNγ‐driven Nrf2 downregulation in microglia as a key target to ameliorate AD pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202304357

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 45

  1. 10.1002/alz.12278 · doi:10.1002/alz.12278
  2. 10.3389/fnagi.2018.00359 · DOI
  3. González‐Reyes R. E., 2017, Frontiers, 10, 427
  4. 10.1038/s41593-020-00735-y · DOI · Paper page
  5. 10.3233/JAD-161118 · DOI · Paper page
  6. 10.1523/JNEUROSCI.22-02-00486.2002 · DOI · Paper page
  7. 10.1016/S0197-4580(00)00124-X · DOI · Paper page
  8. 10.1016/j.trci.2018.06.014 · DOI · Paper page
  9. 10.1046/j.1471-4159.1998.70020699.x · DOI · Paper page
  10. 10.1016/S0306-4522(98)00219-X · DOI · Paper page
  11. 10.1016/S0165-0173(00)00030-8 · DOI · Paper page
  12. 10.1016/j.cell.2017.05.018 · DOI · Paper page
  13. 10.51335/organoid.2021.1.e5 · DOI
  14. 10.1038/s41551-020-00643-3 · DOI
  15. 10.1038/srep01823 · DOI
  16. 10.1073/pnas.222681699 · DOI · Paper page
  17. 10.1016/S0896-6273(03)00434-3 · DOI · Paper page
  18. 10.1016/j.ceb.2015.02.004 · DOI · Paper page
  19. 10.3389/fnana.2017.00077 · DOI · Paper page
  20. 10.1177/1744806918781733 · DOI
  21. 10.1111/cns.13061 · DOI · Paper page
  22. 10.1016/j.bbadis.2018.11.007 · DOI · Paper page
  23. 10.1523/JNEUROSCI.18-24-10445.1998 · DOI · Paper page
  24. 10.1016/0891-0618(96)00148-2 · DOI · Paper page
  25. 10.1038/s41598-020-58422-8 · DOI · Paper page
  26. 10.1155/2015/352723 · DOI · Paper page
  27. 10.1002/glia.22762 · DOI
  28. 10.1089/ars.2017.7342 · DOI · Paper page
  29. 10.1073/pnas.1819541116 · DOI · Paper page
  30. Baird L., 2020, Mol. Cell. Biol., 40
  31. 10.1093/toxsci/kfg083 · DOI · Paper page
  32. 10.3390/antiox11122377 · DOI · Paper page
  33. 10.1016/j.molmed.2023.07.008 · DOI
  34. 10.1038/s41573-018-0008-x · DOI · Paper page
  35. 10.1126/sciadv.abc1428 · DOI
  36. 10.1126/sciadv.abo0789 · DOI
  37. 10.1021/acsami.9b23004 · DOI
  38. 10.4110/in.2018.18.e33 · DOI · Paper page
  39. 10.18632/oncotarget.16990 · DOI
  40. 10.3389/fimmu.2015.00539 · DOI
  41. 10.1371/journal.pone.0162497 · DOI
  42. 10.1046/j.1365-2567.1996.456544.x · DOI
  43. 10.1073/pnas.052159099 · DOI
  44. 10.1016/S0140-6736(16)31679-8 · DOI · Paper page
  45. 10.1111/acel.13153 · DOI

Cited by

See all 27

Metadata

Authors
Kang, Y. J., Hyeon, S. J., McQuade, A., Lim, J., Baek, S. H., Diep, Y. N., Do, K. V., Jeon, Y., Jo, D., Lee, C. J., Blurton‐Jones, M., Ryu, H., & Cho, H.
Affiliations
  • Institute of Quantum Biophysics Sungkyunkwan University Suwon Gyeonggi 16419 Republic of Korea
  • Center for Brain Disorders Brain Science Institute Korea Institute of Science and Technology Seoul 02792 Republic of Korea
  • Institute for Neurodegenerative Diseases University of California San Francisco CA 94158 USA
  • IBS School University of Science and Technology (UST) Daejeon 34114 Republic of Korea
  • School of Pharmacy Sungkyunkwan University Suwon Gyeonggi 16419 Republic of Korea
  • Center for Cognition and Sociality Institute for Basic Science (IBS) Daejeon 34126 Republic of Korea
  • Department of Neurobiology & Behavior University of California Irvine Irvine CA 92697 USA
Venue
Advanced Science
Publisher
Wiley
Published
2024-03-14
Volume
11
Issue
20
ISSN
2198-3844
Cited by
27
References
26
Language
en
Licence
Funders
  • Korea Health Industry Development Institute
  • Korea Dementia Research Center
  • National Research Foundation of Korea (NRF‐2020R1A2C2010285, NRF‐I21SS7606036, NRF‐2022R1I1A1A01063094, NRF‐2022R1I1A1A01072791, NRF‐2021R1C1C2095827, NRF‐2020M3E5D9079742, NRF‐2022R1A2C3013138)
  • Cure Alzheimer's Fund
  • Ministry of Science and ICT, South Korea (HU22C0115, HU23C0217)
  • Korea National Institute of Health (NIH‐AG059236‐01A1, NIH‐AG056303, NIH‐AG055524, NIH‐AG06970101, NIH‐DA048813)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neurotoxic microglial activation via IFNγ-Induced Nrf2 reduction exacerbating alzheimer's disease. https://app.cochat.ai/papers/10.1002/advs.202304357
The paper
Kang, Y. J., Hyeon, S. J., McQuade, A., Lim, J., Baek, S. H., Diep, Y. N., Do, K. V., Jeon, Y., Jo, D., Lee, C. J., Blurton‐Jones, M., Ryu, H., & Cho, H. (2024). Neurotoxic microglial activation via IFNγ-Induced Nrf2 reduction exacerbating alzheimer's disease. Advanced Science. https://doi.org/10.1002/advs.202304357

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.